Investigating long-term effects of allergen immunotherapy in children
Official title: Long Term Effect of AIT in Children
Run by Odense University Hospital · NCT06421415 · Data updated 2026-11-12
This study is testing the long-term effects of allergy treatments in children aged 5 to 18 to see how well they work and if there are any ongoing allergy symptoms or asthma years after treatment.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 4 Years to 18 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Odense University Hospital Academic / other |
| Drugs / interventions | immunotherapy |
| Locations | 2 sites (Odense, Odense C and 1 other locations) |
| Status | Recruiting |
| Started | May 1, 2024 |
| Main results expected | December 1, 2036 |
| Study ends | May 1, 2037 |
| Registry record updated | October 19, 2026 |
| Trial ID | NCT06421415 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are children aged 5 to 18 years who are receiving allergen immunotherapy at the participating hospital.
✕Probably not a fit
Patients who have received less than 12 months of allergen immunotherapy will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to assess the long-term effects of allergen immunotherapy in children aged 5 to 18 years who are treated at Hans Christian Andersen Children's Hospital. Participants will undergo either subcutaneous or sublingual immunotherapy for allergies related to grass pollen, birch, house dust mites, or venom. Data will be collected from patient records, including symptoms, medication use, and test results, with follow-up questionnaires administered 5 and 10 years post-treatment to evaluate ongoing allergy symptoms and asthma. The study will systematically monitor treatment effects and adverse events annually during the treatment period.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the long-term effectiveness of allergen immunotherapy, potentially improving treatment strategies for children with allergies.
How similar studies have gone: While similar studies have explored the effects of allergen immunotherapy, this specific long-term observational approach in children is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: treated with allergen immunotherapy at HCA Children'sHospital, Odense University Hospital - Exclusion Criteria: received less than 12 months of treatment with allergen immunotherapy \-
Where it's running
-
Hans Christian Andersen Children's Hospital
Odense, Odense C, Denmark Recruiting -
Hans Christian Andersen Children's Hospital
Odense, Denmark Recruiting
Study contacts
- Principal investigator: Josefine Gradman, PhD — Odense University Hospital
- Study coordinator: Josefine Gradman, PhD
- Email: josefine.gradman@rsyd.dk
- Phone: 0045 29241375
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Steroids for allergic reactions to food in children
This study will test whether giving steroids in addition to adrenaline and antihistamines helps children who have allergic reactions during supervised food challenges.
-
Investigating allergen provocations in children at HCA Children's Hospital
This study is testing how allergen provocation tests work in children suspected of having food or antibiotic allergies to help improve allergy management.
-
Peanut Oral Immunotherapy for Children in Hong Kong
This study tests whether peanut oral immunotherapy can desensitize children under 18 with peanut allergy in real-world Hong Kong settings compared with standard peanut avoidance.
-
Oral immunotherapy versus natural course for milk and egg allergy in children
This study will see if oral immunotherapy helps children aged 4–10 with cow's milk or hen's egg allergy become desensitized compared with natural evolution.
-
Nickel and LTP sensitization in children with functional gastrointestinal disorders
This research tests whether sensitization to non-specific lipid transfer proteins (LTPs) and to nickel is linked to functional gut symptoms in children aged 4 and older with dyspepsia or irritable bowel symptoms.
-
Rush versus conventional oral immunotherapy for cow's milk and hen's egg allergy in children
This test compares a faster 'rush' oral immunotherapy schedule with a conventional slower schedule to see which better helps children aged 6–16 with milk or egg allergy tolerate those foods.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.